Chun‐Jung Chang

444 total citations
15 papers, 347 citations indexed

About

Chun‐Jung Chang is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chun‐Jung Chang has authored 15 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chun‐Jung Chang's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). Chun‐Jung Chang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). Chun‐Jung Chang collaborates with scholars based in Taiwan and China. Chun‐Jung Chang's co-authors include Chih‐Hung Hsu, Li‐Chun Lu, Bor‐Luen Chiang, Ya‐Hui Chuang, Chun-Ming Lin, Yao‐Hsu Yang, Tsung‐Hao Liu, Ann‐Lii Cheng, Yu‐Yun Shao and I‐Jung Tsai and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Chun‐Jung Chang

15 papers receiving 340 citations

Peers

Countries citing papers authored by Chun‐Jung Chang

Since Specialization

Citations

This map shows the geographic impact of Chun‐Jung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Jung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Jung Chang more than expected).

Fields of papers citing papers by Chun‐Jung Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Jung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Jung Chang. The network helps show where Chun‐Jung Chang may publish in the future.

Co-authorship network of co-authors of Chun‐Jung Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Jung Chang. A scholar is included among the top collaborators of Chun‐Jung Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Jung Chang. Chun‐Jung Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The short- and long-term effects of lower limb endurance training on outpatients with chronic obstructive pulmonary disease 2023 ·Clinical Rehabilitation ·(unknown), Chun‐Jung Chang, (unknown), Ming‐Szu Hung, (unknown), Hui‐Ling Lin	1
2	SHP2: The protein tyrosine phosphatase involved in chronic pulmonary inflammation and fibrosis 2021 ·IUBMB Life ·Chun‐Jung Chang, Chiou‐Feng Lin, (unknown), (unknown), Chia‐Ling Chen	10
3	Association of B cells in tumor microenvironment (TME) with clinical benefit to programmed cell death protein-1 (PD-1) blockade therapy in esophageal squamous cell carcinoma (ESCC). 2021 ·Journal of Clinical Oncology ·(unknown), Chia‐Lang Hsu, (unknown), (unknown), (unknown), Chun‐Jung Chang, (unknown), Chih‐Hung Hsu	2
4	Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis 2020 ·Biochemical Pharmacology ·Chun‐Jung Chang, Chiou‐Feng Lin, Chih‐Hsin Lee, Hsiao‐Chi Chuang, (unknown), Shu-Wen Wan, (unknown), Chia‐Ling Chen	34
5	<p>Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives</p> 2019 ·Journal of Hepatocellular Carcinoma ·Li‐Chun Lu, Chun‐Jung Chang, Chih‐Hung Hsu	53
6	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 2019 ·Liver Cancer ·Li‐Chun Lu, Chiun Hsu, Yu‐Yun Shao, Yee Chao, Chia‐Jui Yen, I‐Lun Shih, Yi‐Ping Hung, Chun‐Jung Chang, Ying‐Chun Shen, (unknown), Tsung‐Hao Liu, Chih‐Hung Hsu, Ann‐Lii Cheng	62
7	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment 2018 ·Liver Cancer ·Li‐Chun Lu, Yi‐Hsuan Lee, Chun‐Jung Chang, Chia‐Tung Shun, Chih‐Yeu Fang, Yu‐Yun Shao, Tsung‐Hao Liu, Ann‐Lii Cheng, Chih‐Hung Hsu	44
8	Factors predicting the total medical costs associated with first-ever ischeamic stroke patients transferred to the rehabilitation ward 2015 ·Journal of Rehabilitation Medicine ·Chien‐Min Chen, Chun‐Jung Chang, Hsiang‐Chin Hsu, Chun-Hsien Lin, Kun Chen	6
9	The Interaction between Circulating Complement Proteins and Cutaneous Microvascular Endothelial Cells in the Development of Childhood Henoch-Schönlein Purpura 2015 ·PLoS ONE ·Yao‐Hsu Yang, I‐Jung Tsai, Chun‐Jung Chang, Ya‐Hui Chuang, (unknown), Bor‐Luen Chiang	39
10	Abstract 461: Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+ myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model 2015 ·Cancer Research ·Chun‐Jung Chang, Yao‐Hsu Yang, (unknown), Bor‐Luen Chiang, (unknown), Chih‐Hung Hsu, Ann‐Lii Cheng	1
11	Identification and characterization of IgA antibodies against β2-glycoprotein I in childhood Henoch-Schönlein purpura 2012 ·British Journal of Dermatology ·Yao‐Hsu Yang, Chun‐Jung Chang, Ya‐Hui Chuang, Hong‐Yuan Hsu, Hsin‐Hui Yu, Jyh‐Hong Lee, Li‐Chieh Wang, Yu‐Tsan Lin, Bor‐Luen Chiang	17
12	Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity 2009 ·Lara D. Veeken ·Yao‐Hsu Yang, Chun‐Jung Chang, Ya‐Hui Chuang, (unknown), Pojen P. Chen, Bor‐Luen Chiang	27
13	Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: Potential for adoptive T cell immunotherapy 2006 ·Clinical Immunology ·Haowei Chen, (unknown), Chingwen Ying, Chun‐Jung Chang, Chun-Ming Lin	26
14	Transforming growth factor-β induces apoptosis in antigen-specific CD4+ T cells prepared for adoptive immunotherapy 2003 ·Immunology Letters ·Chun‐Jung Chang, (unknown), (unknown), Chun-Ming Lin	12
15	Lipopolysaccharide preferentially induces 4-1BB ligand expression on human monocyte-derived dendritic cells 2003 ·Immunology Letters ·(unknown), Chun‐Jung Chang, Chun-Ming Lin	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact